- Filed
- Nov 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Nov 14, 2024 | 161.81M sh |
| Long Term Debt | Q1 2025 · Sep 30, 2024 | $2.27M |
| Short Term Debt | Q1 2025 · Sep 30, 2024 | $291.09K |
| Short Term Debt | Q1 2025 · Jun 30, 2024 | $252.04K |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $39.6K |
| Cash And Equivalents | Q1 2025 · Jun 30, 2024 | $28.86K |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $4.15M |
| Current Liabilities | Q1 2025 · Jun 30, 2024 | $3.51M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $6.39M |
| Total Liabilities | Q1 2025 · Jun 30, 2024 | $5.48M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $970.1K |
| Current Assets | Q1 2025 · Jun 30, 2024 | $834.79K |
| Total Assets | Q1 2025 · Sep 30, 2024 | $5.53M |
| Total Assets | Q1 2025 · Jun 30, 2024 | $4.92M |
| Shares Diluted restated | Q1 2025 · Sep 30, 2023 | 161.81M sh |
| Capex | Q1 2025 · Sep 30, 2023 | $41.67K |
| Operating Cash Flow restated | Q1 2025 · Sep 30, 2023 | −$329.02K |
| Stockholders Equity restated | Q1 2025 · Sep 30, 2023 | −$134.72K |
| Stockholders Equity restated | Q1 2025 · Jun 30, 2023 | $274.82K |
| Eps Diluted | Q1 2025 · Sep 30, 2023 | $0.00 |
| Eps Basic | Q1 2025 · Sep 30, 2023 | $0.00 |
| Sga Expense restated | Q1 2025 · Sep 30, 2023 | $178.13K |
| Net Income restated | Q1 2025 · Sep 30, 2023 | −$386.86K |
| Operating Income | Q1 2025 · Sep 30, 2023 | −$375.77K |
| Gross Profit | Q1 2025 · Sep 30, 2023 | −$197.63K |
| Cost Of Revenue | Q1 2025 · Sep 30, 2023 | $743.51K |
| Revenue | Q1 2025 · Sep 30, 2023 | $545.88K |